Q&A with Venture Life Chief Executive Officer, Jerry Randall
Vox Markets and VLG CEO, Jerry Randal, discuss:
Overview of product portfolio. Start
Attractions of the OTC consumer healthcare sector. 02:10
VLG’s key USPs. 04:20
Integration of BBI Healthcare & Helsinn acquisitions. 07:25
US opportunity. 09:45
Re-invigorating sales in China. 10:55
Distributor/retailer destocking in 2021. 13:45
Managing recent supply chain disruptions. 15:35
Update on Dentyl mouthwash research wrt possible covid protection. 17:55
Product development strategy. 20:30
M&A ambitions. 22:35
Net debt & funding capacity. 26:05
Initial outlook for 2022. 29:20
Board’s longer term targets. 30:45
Future newsflow. 33:00
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.